- Home
- Automated
- List of product information
- VISIPAQUE INJECTION 270 MGI/ML [SIN08882P]
VISIPAQUE INJECTION 270 MGI/ML [SIN08882P]
Active ingredients: VISIPAQUE INJECTION 270 MGI/ML
Last updated 26 October 2025
On this page
Product Info
VISIPAQUE INJECTION 270 MGI/ML
[SIN08882P]
Product information
Active Ingredient and Strength | IODIXANOL - 550 MG/ML |
Dosage Form | INJECTION |
Manufacturer and Country | GE HEALTHCARE IRELAND LIMITED (BY PARAMETRIC RELEASE) - IRELAND |
Registration Number | SIN08882P |
Licence Holder | GE HEALTHCARE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | V08AB09 |
Indications
X-ray contrast medium for cardioangiography, cerebral angiography (conventional), peripheral arteriography (conventional), abdominal angiography (i.a. DSA), urography, venography, CT- enhancement. Lumbar, thoracic and cervical myelography.
Posology and method of administration
The dosage may vary depending on the type of examination, the age, weight, cardiac output and general condition of the patient and the technique used. Usually approximately the same iodine concentration and volume is used as with other iodinated X-ray contrast media in current use, but adequate diagnostic information has also been obtained in some studies with iodixanol injection with somewhat lower iodine concentration. Adequate hydration should be assured before and after administration as for other contrast media. The product is for intravenous, intra-arterial and intrathecal use.
The following dosages may serve as a guide. The doses given for intra-arterial use are for single injections that may be repeated.
Elderly: As for other adults
Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Manifest thyrotoxicosis.